EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optical and MRI-Guided Theranostic Application of Ultrasmall Superparamagnetic Iron Oxide Nanodrug Conjugate for PSMA-Positive Prostate Cancer Therapy

Sharmane Surasinghe, Ioanna Liatsou, Zora Nováková iD, Cyril Bařinka iD, Dmitri Artemov iD, Sudath Hapuarachchige iD

ACS Applied Materials & Interfaces · 26.02.2025 · 17 (8) · 11611-11623

DOI: 10.1021/acsami.4c16009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 11.02.2025. Verfasst von Sharmane Surasinghe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging, Theranostic Nanomedicine, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emerson Collective, Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy, Akademie Ved Cesk? Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance ImagingTheranostic NanomedicineGlutamate Carboxypeptidase IIMagnetite NanoparticlesAntigens, SurfaceMagnetic Iron Oxide NanoparticlesMaleHumansAnimalsMiceCell Line, TumorMice, NudeMaytansineAntibodies, MonoclonalDextrans

Stichwörter der Autor:innen

MRIanti-PSMA antibodyimage-guided drug deliveryoptical imagingprostate cancerprostate-specific membrane antigentargeted therapyultrasmall superparamagnetic iron oxide nanoparticles

Substanzen

Glutamate Carboxypeptidase IIMagnetite NanoparticlesAntigens, SurfaceFOLH1 protein, humanMaytansineAntibodies, MonoclonalDextrans

Autor:innen und Institutionen

  • Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
  • Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland 21205, United States.
  • Laboratory of Structural Biology, Institute of Biotechnology of the Czech Academy of Sciences, Vestec 252 50, Czech Republic.
  • Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States.

ORCID-Profile: Zora Nováková, Cyril Bařinka, Dmitri Artemov, Sudath Hapuarachchige

Förderung

  • Emerson Collective
  • Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy
  • Akademie Ved Cesk? Republiky
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Surasinghe, S., Liatsou, I., Nováková, Z., Bařinka, C., Artemov, D., & Hapuarachchige, S. (2025). Optical and MRI-Guided Theranostic Application of Ultrasmall Superparamagnetic Iron Oxide Nanodrug Conjugate for PSMA-Positive Prostate Cancer Therapy. ACS Applied Materials & Interfaces, 17(8), 11611-11623. https://doi.org/10.1021/acsami.4c16009

Vancouver

Surasinghe S, Liatsou I, Nováková Z, Bařinka C, Artemov D, Hapuarachchige S. Optical and MRI-Guided Theranostic Application of Ultrasmall Superparamagnetic Iron Oxide Nanodrug Conjugate for PSMA-Positive Prostate Cancer Therapy. ACS Applied Materials & Interfaces. 2025;17(8):11611-11623. doi:10.1021/acsami.4c16009

BibTeX
@article{Surasinghe2025,
  author = {Surasinghe, Sharmane and Liatsou, Ioanna and Nováková, Zora and Bařinka, Cyril and Artemov, Dmitri and Hapuarachchige, Sudath},
  title = {Optical and MRI-Guided Theranostic Application of Ultrasmall Superparamagnetic Iron Oxide Nanodrug Conjugate for PSMA-Positive Prostate Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {11611--11623},
  doi = {10.1021/acsami.4c16009}
}
Kostenlos starten →